“…(60.8 mg, 0.19 mmol, 63%). The spectral data matched that reported: 15 TLC (hexane/EtOAc 80:20) R f 0.28: 1 H NMR (300 MHz, CDCl 3 ) δ 8.08 (ddd, J = 15.2, 7.7, 1.3 Hz, 1H), 7.51 -7.44 (m, 1H), 7.35 -7.09 (m, 13H), 2.76 (d, J = 1.8 Hz, 3H) ppm; 13 C NMR { 1 H} (75 MHz, CDCl 3 ) δ 150.5 (d, 2 J C-P = 7.8 Hz, 2xC 1' ), 142.2 (d, 2 J C-P = 10.6 Hz, C 2 -Me), 134.5 (d, 2 J C-P = 11.1 Hz, C 6 -H), 133.4 (d, 4 J C-P = 3.1 Hz, C 4 -H), 131.6 (d, 3 J C-P = 15.8 Hz, C 3 -H), 129.8 (4xC 3' -H), 125.79 (d, 3 J C-P = 15.8 Hz, C 5 -H), 125.73 (d, J C-P = 188.6 Hz, C-P), 125.1 (d, 5 J C-P = 1.2Hz, 2xC 4' -H), 120.5 (d, 3 J C-P = 4.6 Hz, 4xC 2' -H), 21.6 (d, 3 J C-P = 3.6 Hz, CH 3 ) ppm; LRMS (EI) m/z (%) 324 (M + , 100), 288 (18), 231(25), 212(30), 77 (54).Diphenyl[1,1'-biphenyl]-2-ylphosphonate (2s). Following the general procedure, compound 2s was obtained after FC (from 95:5 to 80:20 hexane/EtOAc) and further purified by recrystallization from i-PrOH as an orange crystalline solid (67.2 mg, 0.174 mmol, 58%): TLC (hexane/EtOAc 80:20) R f 0.30; mp (i-PrOH) 93-95 ºC; 1 H NMR (300 MHz, CDCl 3 ) δ 8.36 -8.27 (m, 1H), 7.65 (tt, J = 7.6, 1.6 Hz, 1H), 7.54 (dtd, J = 7.6, 3.8, 1.4 Hz, 1H), 7.51 -7.46 (m, 2H), 7.45 -7.38 (m, 4H), 7.25 -7.17 (m, 4H), 7.13 -7.05 (m, 2H), 6.93 -6.86 (m, 4H); C NMR { 1 H} (75 MHz, CDCl 3 ) δ 150.5 (d, 2 J C-P = 8.4 Hz, 2xC 1' ), 146.6 (d, 2 J C-P = 10.0 Hz, C 2 ), 141.2 (d, 3 J C-P = 4.2 Hz, C 7 ), 134.6 (d, 2 J = 10.8 Hz, C 6 -H), 133.0 (d, 4 J C-P = 3.1 Hz, C 4 -H), 131.9 (d, 3 J C-P = 14.9 Hz, C 5 -H), 129.7 (2xC 9 -H), 129.6 (4xC 3' -H), 127.8 (C 10 -H), 127.8 (2xC 8 -H), 127.2 (d, 3 J C-P = 15.6 Hz, C 3 -H), 125.…”